Protocol · Cancer Support
Cancer-Related Pain Supportive Care Protocol
Vitamin D and Omega-3 Fatty Acids are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Cancer-Related Pain Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (higher doses may be needed; monitor levels) | Deficiency common in cancer and may worsen pain; supplementation may reduce opioid requirements | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory effects; may help with pain and cachexia | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Magnesium | Amount listed: 300–400 mg daily | NMDA receptor modulation; may enhance analgesic effects and reduce neuropathic pain | Not graded yet | |
| Curcumin | Amount listed: 500–1,000 mg daily (enhanced absorption formulation) | Anti-inflammatory and analgesic properties; may complement conventional pain management | Not graded yet | |
| Ginger | Amount listed: 500 mg-1 g daily | Anti-inflammatory; helps with chemotherapy-related nausea and may have analgesic effects | Not graded yet | |
| Probiotics | Amount listed: 20–50 billion CFU daily | Supports gut health; may help with opioid-induced constipation and treatment side effects | Not graded yet | |
| Alpha-Lipoic Acid | Amount listed: 300–600 mg daily | May help with chemotherapy-induced peripheral neuropathy (CIPN) | Not graded yet | |
| L-Carnitine | Amount listed: 1–3 g daily | May help with chemotherapy-induced neuropathy and cancer-related fatigue | Not graded yet | |
How this protocol works
In plain language
Cancer pain can arise from the tumor itself (invading tissues, compressing nerves), from cancer treatment (surgery, radiation, chemotherapy-induced neuropathy), or from general debility. It affects 50-70% of cancer patients and up to 90% of those with advanced disease. Pain significantly impacts quality of life and should be aggressively managed. Types include nociceptive pain (bone, visceral), neuropathic pain (nerve damage), and mixed patterns.
CRITICAL: Cancer pain requires comprehensive management by an oncology team, often with palliative care or pain medicine specialists. The WHO analgesic ladder (non-opioids → weak opioids → strong opioids ± adjuvants) guides treatment. Medications include: NSAIDs/acetaminophen, opioids (morphine, oxycodone, fentanyl), adjuvants for neuropathic pain (gabapentin, pregabalin, duloxetine). Interventional procedures (nerve blocks, spinal pumps) help selected patients. These supplements may provide adjunctive support but are NOT replacements for proper pain medication. Undertreated cancer pain is unacceptable - advocate for adequate pain control.
Vitamin D* deficiency is very common in cancer patients and may worsen pain perception. A trial showed vitamin D supplementation reduced opioid dose requirements.
Omega-3 Fatty Acids* have anti-inflammatory effects and may help with both pain and cancer-related cachexia.
Magnesium* modulates NMDA receptors involved in pain processing and may help with neuropathic pain and opioid tolerance.
Curcumin* has anti-inflammatory and analgesic properties.
Ginger* helps with chemotherapy-related nausea and has some analgesic properties.
Probiotics* support gut health, especially important when constipation from opioids is an issue.
Alpha-Lipoic Acid and L-Carnitine* may help with chemotherapy-induced peripheral neuropathy, a painful and difficult-to-treat condition.
Expected timeline: Pain management requires ongoing adjustment. Supplements provide gradual supportive benefits over weeks. Always prioritize adequate conventional pain control first.